Shmerling James E.
- SEC CIK
- 0001505051
No open-market purchases or sales filed in the past year.
Current role at each company
- HRGN Harvard Apparatus Regenerative Technology, Inc.Directoras of Jul 1, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Shmerling James E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | Shmerling James E.Director | PPurchase | +6.86K | $4.35 | +$29.9K | +40.6%23.8K after | |
| May 23, 2022 (view filing) | May 12 | 11 daysLate | Shmerling James E.Director | PPurchase | +16.9K | $5.92 | +$100.0K | New position16.9K after | |
| May 23, 2022 (view filing) | May 12 | 11 daysLate | Shmerling James E.Director | PPurchase | +8.45K | – | – | –8.45K after | Derivative |